Development of Targeted Alpha Therapy from Bench to Bedside

This review briefly describes recent promising developments of alpha emitter labelled compounds for targeted alpha therapy of bladder cancer, brain tumours, neuroendocrine tumours, and prostate cancer.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of medical imaging and radiation sciences 2019-12, Vol.50 (4), p.S18-S20
Hauptverfasser: Morgenstern, Alfred, Bruchertseifer, Frank
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page S20
container_issue 4
container_start_page S18
container_title Journal of medical imaging and radiation sciences
container_volume 50
creator Morgenstern, Alfred
Bruchertseifer, Frank
description This review briefly describes recent promising developments of alpha emitter labelled compounds for targeted alpha therapy of bladder cancer, brain tumours, neuroendocrine tumours, and prostate cancer.
doi_str_mv 10.1016/j.jmir.2019.06.046
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2272732964</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1939865419303418</els_id><sourcerecordid>2272732964</sourcerecordid><originalsourceid>FETCH-LOGICAL-c422t-29ea3ed763ca18890498059911d206796634b2837973f761fd0aecdf2d3013e23</originalsourceid><addsrcrecordid>eNp9kDtPwzAUhS0EoqXwBxhQRpYEP1I_BEspT6kSS5kt176hqZI62Gml_ntctTAy3TN850j3Q-ia4IJgwu9WxaqtQ0ExUQXmBS75CRoSKXgulKSnKSumcsnH5QBdxLjCmFMh1DkaMFLisSRyiO6fYAuN71pY95mvsrkJX9CDyyZNtzTZfAnBdLusCr7NHmFtl1nvU3CxdnCJzirTRLg63hH6fHmeT9_y2cfr-3Qyy21JaZ9TBYaBE5xZQ6RUuFQSj5UixFHMheKclQsqmVCCVYKTymED1lXUMUwYUDZCt4fdLvjvDcRet3W00DRmDX4TNaWCCkYVLxNKD6gNPsYAle5C3Zqw0wTrvTS90ntpei9NY66TtFS6Oe5vFi24v8qvpQQ8HABIX25rCDraOskAVwewvXa-_m__B4a8e1M</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2272732964</pqid></control><display><type>article</type><title>Development of Targeted Alpha Therapy from Bench to Bedside</title><source>Access via ScienceDirect (Elsevier)</source><creator>Morgenstern, Alfred ; Bruchertseifer, Frank</creator><creatorcontrib>Morgenstern, Alfred ; Bruchertseifer, Frank</creatorcontrib><description>This review briefly describes recent promising developments of alpha emitter labelled compounds for targeted alpha therapy of bladder cancer, brain tumours, neuroendocrine tumours, and prostate cancer.</description><identifier>ISSN: 1939-8654</identifier><identifier>EISSN: 1876-7982</identifier><identifier>DOI: 10.1016/j.jmir.2019.06.046</identifier><identifier>PMID: 31405818</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>actinium-225 ; alpha emitter ; bismuth-213 ; clinical application ; Targeted alpha therapy</subject><ispartof>Journal of medical imaging and radiation sciences, 2019-12, Vol.50 (4), p.S18-S20</ispartof><rights>2019</rights><rights>Copyright © 2019. Published by Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c422t-29ea3ed763ca18890498059911d206796634b2837973f761fd0aecdf2d3013e23</citedby><cites>FETCH-LOGICAL-c422t-29ea3ed763ca18890498059911d206796634b2837973f761fd0aecdf2d3013e23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jmir.2019.06.046$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31405818$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Morgenstern, Alfred</creatorcontrib><creatorcontrib>Bruchertseifer, Frank</creatorcontrib><title>Development of Targeted Alpha Therapy from Bench to Bedside</title><title>Journal of medical imaging and radiation sciences</title><addtitle>J Med Imaging Radiat Sci</addtitle><description>This review briefly describes recent promising developments of alpha emitter labelled compounds for targeted alpha therapy of bladder cancer, brain tumours, neuroendocrine tumours, and prostate cancer.</description><subject>actinium-225</subject><subject>alpha emitter</subject><subject>bismuth-213</subject><subject>clinical application</subject><subject>Targeted alpha therapy</subject><issn>1939-8654</issn><issn>1876-7982</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp9kDtPwzAUhS0EoqXwBxhQRpYEP1I_BEspT6kSS5kt176hqZI62Gml_ntctTAy3TN850j3Q-ia4IJgwu9WxaqtQ0ExUQXmBS75CRoSKXgulKSnKSumcsnH5QBdxLjCmFMh1DkaMFLisSRyiO6fYAuN71pY95mvsrkJX9CDyyZNtzTZfAnBdLusCr7NHmFtl1nvU3CxdnCJzirTRLg63hH6fHmeT9_y2cfr-3Qyy21JaZ9TBYaBE5xZQ6RUuFQSj5UixFHMheKclQsqmVCCVYKTymED1lXUMUwYUDZCt4fdLvjvDcRet3W00DRmDX4TNaWCCkYVLxNKD6gNPsYAle5C3Zqw0wTrvTS90ntpei9NY66TtFS6Oe5vFi24v8qvpQQ8HABIX25rCDraOskAVwewvXa-_m__B4a8e1M</recordid><startdate>201912</startdate><enddate>201912</enddate><creator>Morgenstern, Alfred</creator><creator>Bruchertseifer, Frank</creator><general>Elsevier Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201912</creationdate><title>Development of Targeted Alpha Therapy from Bench to Bedside</title><author>Morgenstern, Alfred ; Bruchertseifer, Frank</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c422t-29ea3ed763ca18890498059911d206796634b2837973f761fd0aecdf2d3013e23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>actinium-225</topic><topic>alpha emitter</topic><topic>bismuth-213</topic><topic>clinical application</topic><topic>Targeted alpha therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Morgenstern, Alfred</creatorcontrib><creatorcontrib>Bruchertseifer, Frank</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medical imaging and radiation sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Morgenstern, Alfred</au><au>Bruchertseifer, Frank</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Development of Targeted Alpha Therapy from Bench to Bedside</atitle><jtitle>Journal of medical imaging and radiation sciences</jtitle><addtitle>J Med Imaging Radiat Sci</addtitle><date>2019-12</date><risdate>2019</risdate><volume>50</volume><issue>4</issue><spage>S18</spage><epage>S20</epage><pages>S18-S20</pages><issn>1939-8654</issn><eissn>1876-7982</eissn><abstract>This review briefly describes recent promising developments of alpha emitter labelled compounds for targeted alpha therapy of bladder cancer, brain tumours, neuroendocrine tumours, and prostate cancer.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>31405818</pmid><doi>10.1016/j.jmir.2019.06.046</doi></addata></record>
fulltext fulltext
identifier ISSN: 1939-8654
ispartof Journal of medical imaging and radiation sciences, 2019-12, Vol.50 (4), p.S18-S20
issn 1939-8654
1876-7982
language eng
recordid cdi_proquest_miscellaneous_2272732964
source Access via ScienceDirect (Elsevier)
subjects actinium-225
alpha emitter
bismuth-213
clinical application
Targeted alpha therapy
title Development of Targeted Alpha Therapy from Bench to Bedside
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T10%3A27%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Development%20of%20Targeted%20Alpha%20Therapy%20from%20Bench%20to%20Bedside&rft.jtitle=Journal%20of%20medical%20imaging%20and%20radiation%20sciences&rft.au=Morgenstern,%20Alfred&rft.date=2019-12&rft.volume=50&rft.issue=4&rft.spage=S18&rft.epage=S20&rft.pages=S18-S20&rft.issn=1939-8654&rft.eissn=1876-7982&rft_id=info:doi/10.1016/j.jmir.2019.06.046&rft_dat=%3Cproquest_cross%3E2272732964%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2272732964&rft_id=info:pmid/31405818&rft_els_id=S1939865419303418&rfr_iscdi=true